Short Takes

August 2010 Issue

Short Takes: August 2010

Diabetes mellitus (DM) is a common endocrine disease in cats, and it is becoming a model for DM in humans because cats develop a form of the disease that is similar to the human type-2 diabetes mellitus. Amylin is a normal secretory product of pancreatic beta cells, and it plays an important role in controlling nutrient fluctuations. Amylin has become an established therapy along with insulin in human diabetics because it reduces post-prandial glucagon secretion and slows gastric emptying. This study ("Amylin reduces plasma glucagon concentration in cats," The Veterinary Journal, 2010) was the first to investigate if amylin reduces plasma glucagon levels in cats.

To continue reading this entire article you must be a paid subscriber.

Subscribe to CatWatch Newsletter

Which foods are really safe for your cat? How can you painlessly end furniture scratching---for good? What is your cat telling you when she refuses to eat? Get the answers to these questions- and many more- when you subscribe now to CatWatch!

Already subscribe but haven't registered for all the benefits of the website? Click here.

Subscriber Log In

Forgot your password? Click Here.